Improving Shared Decision Making in Hemophilia: Visiting Professorship Program Grant
Funding Amount
Up to US $7,500
Deadline
Deadline not published
Grant Type
Foundation
Overview
The Improving Shared Decision Making in Hemophilia Visiting Professorship Program, sponsored by Pfizer and HTRS, aims to enhance educational resources for organizations with limited access to hemophilia expertise. This initiative invites clinicians and multidisciplinary teams to host a distinguished Visiting Professor who will address unmet educational needs in shared decision making and emerging therapies. Grants of up to $7,500 will support local program costs, with a focus on enhancing care for patients with hemostatic disorders.
Improving Shared Decision Making in Hemophilia: Visiting Professorship Program
Overview
Pfizer and the Hemostasis & Thrombosis Research Society (HTRS) are offering a new Independent Medical Education grant opportunity supporting Visiting Professorships for organizations with limited hemophilia-focused resources and experience.
Clinicians, physician-scientists, and multidisciplinary care teams at recipient organizations will host and coordinate a medical education program led by a distinguished Visiting Professor with expertise matched to specific unmet educational needs surrounding shared decision making (SDM) and emerging therapeutic options in hemophilia.
About Hemostasis & Thrombosis Research Society
The Hemostasis and Thrombosis Research Society, Inc. (HTRS) is the leading North American professional society dedicated to research, mentoring, workforce development, and continuing medical education for physicians, investigators, and all health care professionals interested in advancing care for people with hemostatic and thrombotic disorders.
Expected Approximate Monetary Range of Grant Applications
Individual grant amounts will be up to $7,500 USD to cover local costs (e.g., meeting room rental, AV support, local onsite management, onsite logistics, or planning and staffing needs)Please note: HTRS will select one Visiting Professor based on the recipient’s approved program and knowledge gaps. Travel expenses and honoraria for the Visiting Professor will be covered separately and should not be a part of your grant application budget.Approximately eight (8) sites will be supported by this educational program
What The Pfizer Foundation Inc actually gave
Source: IRS Form 990-PF, 2024
- Grants in 2024
- 9,306
- Total given
- $23.24M
Focus Areas & Funding Uses
Fields of Work
- Healthcare
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Bronchoscopy Research Grant
Intuitive Foundation
Amount
Up to US $75,000
Deadline
January 4, 2027
Listed date — confirm with the funder
Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma Grant
The Pfizer Foundation Inc
Amount
US $50,000 - US $200,000
Deadline
Deadline not published
Pfizer Clostridioides difficile (C. difficile) Research Collaboration Grant
The Pfizer Foundation Inc
Amount
Up to US $500,000
Deadline
Deadline not published
Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC) Grant
The Pfizer Foundation Inc
Amount
US $150,000 - US $250,000
Deadline
Deadline not published
RD Global Monitoring anti-TFPI RES
The Pfizer Foundation Inc
Amount
Varies
Deadline
Deadline not published
Independent Medical Education Grant - Annual Meetings
The Pfizer Foundation Inc
Amount
Varies
Deadline
Deadline not published
Ready to apply for Improving Shared Decision Making in Hemophilia: Visiting Professorship Program Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Improving Shared Decision Making in Hemophilia: Visiting Professorship Program Grant. Now let's win it.